Bleeding Risk Following Percutaneous Coronary Intervention in Patients with Diabetes Prescribed Dual Anti-platelet Therapy

BACKGROUND: Patients with diabetes (DM) experience higher rates of in-stent restenosis and greater benefit from DES implant at the time of PCI, necessitating prolonged dual anti-platelet therapy (DAPT). While DAPT reduces risk of ischemic events post-PCI, it also increases risk of bleeding. Whether...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am Heart J
Päätekijät: Grodzinsky, Anna, Arnold, Suzanne V., Wang, Tracy Y., Sharma, Praneet, Gosch, Kensey, Jones, Philip G., Bhatt, Deepak L., Steg, Philippe Gabriel, McGuire, Darren K., Cohen, David J., Spertus, John A., Chhatriwalla, Adnan K., Lind, Marcus, Graham, Garth, Kosiborod, Mikhail
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5357237/
https://ncbi.nlm.nih.gov/pubmed/27914490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2016.09.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia